ArticleOncology reports2021

[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer.

Fei Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.